Maxcyte (MXCT) Accounts Payables (2020 - 2026)
Maxcyte (MXCT) posted quarterly Accounts Payables of $1.2 million for Q1 2026, down 47.52% year-over-year from $2.3 million in Q1 2025, and down 14.63% quarter-over-quarter from $1.4 million in Q4 2025.
Maxcyte (MXCT) Accounts Payables (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Accounts Payables for 7 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 47.52% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 47.52% YoY), while the FY2025 annual figure was $1.4 million, up 3.17% from the prior year.
- Accounts Payables eased to $1.2 million in Q1 2026 per MXCT's latest filing, from $1.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $4.4 million in Q1 2022 and bottomed at $292000.0 in Q4 2022.
- Historically, Accounts Payables has averaged $1.7 million across 5 years, with a median of $1.4 million in 2025.
- Annual changes were most pronounced in 2022 — Accounts Payables plunged 83.96% — and 2024, when it soared 317.6%.
- Maxcyte's Accounts Payables stood at $292000.0 in 2022, then jumped by 154.45% to $743000.0 in 2023, then jumped by 82.77% to $1.4 million in 2024, then climbed by 3.17% to $1.4 million in 2025, then slipped by 14.63% to $1.2 million in 2026.
- Business Quant data shows MXCT's Accounts Payables at $1.2 million in Q1 2026, $1.4 million in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 2.28 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 953,000.00 |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 743,000.00 |
| Sep 30, 2023 | 446,600.00 |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 3.50 Mn |
| Dec 31, 2022 | 292,000.00 |
| Sep 30, 2022 | 2.09 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 4.37 Mn |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 723,300.00 |